Gene · 88
Papers1,598
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,598
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Screening of potential regulatory genes in carotid atherosclerosis vascular immune microenvironment. | PLoS One | 2024 | 39652562 | PubTator, text mining | PubMed |
| Evaluation of EDARADD, LPO and ACTN2 genes polymorphisms in children with dental caries compared to caries-free controls. | J Clin Pediatr Dent | 2024 | 39543892 | PubTator, text mining | PubMed |
| Lnc-LINC00511 promotes gastric cancer progression by regulating MiR-29c-3p/TRIP13 axis through AKT/mTOR pathway. | Int J Biol Macromol | 2024 | 39389496 | PubTator, text mining | PubMed |
| CCDC78: Unveiling the Function of a Novel Gene Associated with Hereditary Myopathy. | Cells | 2024 | 39273074 | PubTator, text mining | PubMed |
| Spatiotemporal changes and driving factors of alpine land cover in Tianshan world natural heritage sites. | Sci Rep | 2024 | 39245664 | PubTator, text mining | PubMed |
| Cardiac ACTN2 enhancer regulates cardiometabolism and maturation. | Nat Cardiovasc Res | 2024 | 39196224 | PubTator, text mining | PubMed |
| Human induced pluripotent stem cells for live cell cycle monitoring and endogenous gene activation. | Stem Cell Res | 2024 | 39128210 | PubTator, text mining | PubMed |
| Protein-extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation. | Ann Clin Transl Neurol | 2024 | 39095936 | PubTator, text mining | PubMed |
| AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice. | Skelet Muscle | 2024 | 39044305 | PubTator, text mining | PubMed |
| Current advance on distal myopathy genetics. | Curr Opin Neurol | 2024 | 39017652 | PubTator, text mining | PubMed |
| Actn2 defects accelerates H9c2 hypertrophy via ERK phosphorylation under chronic stress. | Genes Genomics | 2024 | 38990270 | PubTator, text mining | PubMed |
| Sudden Cardiac Death, Post-Mortem Investigation: A Proposing Panel of First Line and Second Line Genetic Tests. | J Pers Med | 2024 | 38793126 | PubTator, text mining | PubMed |
| Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes. | Biologics | 2024 | 38746773 | PubTator, text mining | PubMed |
| scEWE: high-order element-wise weighted ensemble clustering for heterogeneity analysis of single-cell RNA-sequencing data. | Brief Bioinform | 2024 | 38701413 | PubTator, text mining | PubMed |
| Investigation of mutation spectrum amongst patients with familial primary cardiomyopathy using targeted NGS in Indian population. | J Appl Genet | 2024 | 38551768 | PubTator, text mining | PubMed |
| Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts. | J Cancer Res Clin Oncol | 2024 | 38526631 | PubTator, text mining | PubMed |
| Exercise-Dependent Modulation of Immunological Response Pathways in Endurance Athletes With and Without Atrial Fibrillation. | J Am Heart Assoc | 2024 | 38497478 | PubTator, text mining | PubMed |
| A passage-free, simplified, and scalable novel method for iPSC generation in three-dimensional culture. | Regen Ther | 2024 | 38496009 | PubTator, text mining | PubMed |
Signatures of cysteine oxidation on muscle structural and contractile proteins are associated with physical performance and muscle function in older adults: Study of Muscle, Mobility and Aging (SOMMA). | Aging Cell | 2024 | 38332629 | PubTator, text mining | PubMed |
| Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy. | Ann Clin Transl Neurol | 2024 | 38311799 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/88/papers?page=4